Thermo Fisher and Symphogen continue biopharma collaboration
Therapeutic: ivosidenib for cholangiocarcinoma
Servier and X-Chem team up on drug discovery
Servier acquires therapeutic antibody discovery specialist Symphogen
Pall Corporation wins supply contract with Servier
Servier begins construction of Paris-Saclay cluster facility
Servier brings acclaimed journalist and mountaineer to ASCO 2019
Servier and Oncodesign join forces to investigate new Parkinson's drug
Bringing preparative chromatography into the spotlight
Shire announces sale of oncology business to Servier for $2.4 billion
Three milestones in Servier and Vernalis oncology drug discovery collaboration
Servier and Vernalis announce three milestones in their oncology drug discovery collaboration
Vernalis and Servier enter drug discovery collaboration
Servier appoints MaSTherCell to develop its cell therapy manufacturing platform
GeNeuro and Servier announce ANGEL-MS extension clinical study in multiple sclerosis
